Lexaria Bioscience Corp.
Lexaria Bioscience Corp. (NASDAQ: LEXX) is trading at $3.39, about ₹326 at today's USD/INR rate, as of 25 Sep 2026, 3:59 PM ET, up 0.59% today. Indian residents can buy Lexaria Bioscience from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$3.15
Today's high
$3.46
52 week low
$2.80
52 week high
$21.60
LEXX opened at $3.46, closed previously at $3.37, and has traded between $2.80 and $21.60 over the past 52 weeks.
About
Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also drastically cuts the time of onset from hours to mere minutes and effectively neutralizes unpleasant tastes. Beyond its established uses, the technology is currently under evaluation for its potential application with orally administered antiviral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and various other compounds. A notable feature of DehydraTECH is its capacity to facilitate the passage of drugs across the blood-brain barrier. The company operates a licensed internal research facility and holds a substantial intellectual property portfolio, comprising 23 granted patents and roughly 50 pending patent applications globally. Founded in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.
Key statistics
Avg. volume
40.81K
Market cap
$5.60M
P/E Ratio
-0.64
Price-to-sales ratio
28.88
Enterprise value
$2.21M
Free cash flow yield
-134.37%
Debt-to-equity ratio
0.02
Return on equity
-160.72%
ROIC
-173.96%
Beta
0.34
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$705.92K
Earnings per share
-$9.90
Free cash flow
-$10.48M
Net profit margin
-3985.58%
Gross margin
100.00%
EBITDA
-$11.82M
Revenue growth
52.05%
Similar securities
This is not an investment recommendation
How to buy Lexaria Bioscience from India
Indian residents can buy Lexaria Bioscience shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Lexaria Bioscience and place an order
Find Lexaria Bioscience by name or by its ticker, LEXX, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Lexaria Bioscience trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Lexaria Bioscience position in USD and INR. Lexaria Bioscience pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Lexaria Bioscience from India
Trading and taxes when buying Lexaria Bioscience from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneLexaria Bioscience does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Lexaria Bioscience stock?
Yes. Lexaria Bioscience (LEXX) has been listed on NASDAQ since 2021, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Lexaria Bioscience share cost in rupees?
One Lexaria Bioscience share is $3.39 — about ₹326 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the Lexaria Bioscience price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Lexaria Bioscience from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Lexaria Bioscience?
Yes. One Lexaria Bioscience share is $3.39, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Lexaria Bioscience.
How are gains on Lexaria Bioscience shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Lexaria Bioscience price. Paasa issues a capital-gains statement for your return.
Does Lexaria Bioscience pay a dividend?
No. Lexaria Bioscience does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Lexaria Bioscience from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is Lexaria Bioscience a United States company, and does that change how it is taxed?
Lexaria Bioscience trades on NASDAQ in US dollars, but the company is domiciled in Canada. Lexaria Bioscience trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare Lexaria Bioscience shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Lexaria Bioscience holding, its cost and its closing value.
How do I sell Lexaria Bioscience and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.